What are the major opportunities in the Oncology Precision Medicine market? What are the strategies for the Oncology Precision Medicine market?

For detailed insights on the major opportunities and strategies in the Oncology Precision Medicine market, Read More

How does the Oncology Precision Medicine market relate to the overall economy and other similar markets?

For detailed insights on Oncology Precision Medicine's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Oncology Precision Medicine market growth? SWOT analysis of the Oncology Precision Medicine market.

For detailed insights on the key dynamics influencing the Oncology Precision Medicine market growth and SWOT analysis of the Oncology Precision Medicine industry, Read More

Global Oncology Precision Medicine Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Oncology Precision Medicine Global Market Report 2025

Name: Oncology Precision Medicine Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product Type (Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs), By Technology (Genomics, Proteomics, Bioinformatics, Other Technologies), By Biomarker Types (Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types), By Applications (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications), By End-Users (Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Oncology Precision Medicine Market Overview

• Oncology Precision Medicine market size has reached to $110.90 billion in 2024

• Expected to grow to $201.40 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%

• Growth Driver: The Growing Prevalence Of Cancer Is Enhancing The Market Growth Due To Aging Populations

• Market Trend: Advancing Personalized Cancer Care Through Collaborative Technology And Multidisciplinary Expertise

• North America was the largest region in 2024.

What Is Covered Under Oncology Precision Medicine Market?

Oncology precision medicine refers to a personalized approach to cancer care that uses genetic, molecular, and clinical information to tailor treatment strategies to the individual characteristics of each patient’s tumor. It aims to improve outcomes by selecting therapies that specifically target the unique biological features of a patient’s cancer, leading to more effective and less toxic treatments.

The main product types in oncology precision medicine are diagnostics, therapeutics, inhibitor drugs, monoclonal antibodies, cell and gene therapy, and antiviral and anti-retroviral drugs. Diagnostics is the process of identifying diseases or medical conditions through examination, testing, and analysis of symptoms or samples. The key technologies are genomics, proteomics, bioinformatics, and others. Different biomarker types are genetic biomarkers, protein biomarkers, epigenetic biomarkers, metabolic biomarkers, and others. The various applications involved are breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer, kidney cancer, liver cancer, bladder cancer, and others, and they are used by several end users such as hospitals, diagnostic laboratories, research institutions, pharmaceutical companies, and others.

Oncology Precision Medicine Market Size and growth rate 2025 to 2029: Graph

What Is The Oncology Precision Medicine Market Size 2025 And Growth Rate?

The oncology precision medicine market size has grown rapidly in recent years. It will grow from $110.90 billion in 2024 to $125.14 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to rising prevalence of cancer cases, increasing adoption of targeted therapies, growing investments in genomic research, expanding healthcare infrastructure, and rising awareness about personalized medicine.

What Is The Oncology Precision Medicine Market Growth Forecast?

The oncology precision medicine market size is expected to see rapid growth in the next few years. It will grow to $201.40 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing demand for non-invasive cancer diagnostics, growing preference for individualized treatment approaches, rising use of companion diagnostics, expanding pipeline of precision oncology drugs, and increasing clinical adoption of artificial intelligence tools. Major trends in the forecast period include technology advancements in liquid biopsy platforms, innovations in next-generation sequencing, developments in artificial intelligence for data analysis, research and developments in biomarker discovery, and integration of multi-omics in clinical oncology.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Oncology Precision Medicine Market Segmented?

1) By Product Type: Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs

2) By Technology: Genomics, Proteomics, Bioinformatics, Other Technologies

3) By Biomarker Types: Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types

4) By Applications: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications

5) By End-Users: Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Diagnostics: Companion Diagnostics, Molecular Diagnostics, Liquid Biopsy, Imaging Diagnostics, Next-Generation Sequencing Assays

2) By Therapeutics: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

3) By Inhibitor Drugs: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

4) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, Radiolabeled Antibodies

5) By Cell And Gene Therapy: CAR-T Cell Therapies, T-Cell Receptor (TCR) Therapies, Tumor-Infiltrating Lymphocyte (TIL) Therapies, Oncolytic Viral Therapies, Gene Editing And Replacement Therapies

6) By Antiviral And Anti-Retroviral Drugs: Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Entry Inhibitors, Antiviral Agents Targeting Virus-Related Cancers

What Is Driving The Oncology Precision Medicine Market? The Growing Prevalence Of Cancer Is Enhancing The Market Growth Due To Aging Populations

The growing prevalence of cancer is expected to propel the growth of the oncology precision medicine market going forward. Cancer is a disease in which abnormal cells grow uncontrollably and can spread to other parts of the body, disrupting normal bodily functions. The growing prevalence of cancer is due to aging populations, as prolonged lifespans lead to the accumulation of deoxyribonucleic acid (DNA) mutations, diminished repair systems, chronic inflammaging, weakening immune surveillance, and tissue microenvironments that increasingly support tumor growth. Oncology precision medicine is useful for cancer by providing personalized treatments based on the unique genetic makeup of each tumor, improving effectiveness and reducing side effects. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the estimated 20 million new cases of cancer in 2022 are expected to rise by 77% to over 35 million cases in 2050. Therefore, the growing prevalence of cancer is driving the growth of the oncology precision medicine industry.

Who Are The Major Players In The Global Oncology Precision Medicine Market?

Major companies operating in the oncology precision medicine market are Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc.

What Are The Key Trends Of The Global Oncology Precision Medicine Market? Advancing Personalized Cancer Care Through Collaborative Technology And Multidisciplinary Expertise

Major companies operating in the oncology precision medicine market are focusing on developing innovative solutions, such as molecular tumor board initiatives, to facilitate multidisciplinary collaboration and optimize personalized treatment planning. Molecular tumor boards are multidisciplinary teams of experts who review and interpret complex genetic and molecular test results to recommend personalized cancer treatment strategies. For instance, in April 2025, McKesson Corporation, a US-based healthcare services and information technology company, launched the Precision Care Companion initiative to support biomarker-driven cancer care by providing education, technology enhancements, and operational assistance to oncology practices. This comprehensive program brings together physicians, clinical staff, business leaders, and pharmaceutical partners to create a collaborative environment that speeds the integration of advanced genomic testing and targeted therapies, ultimately helping providers deliver more personalized and effective cancer treatments while improving patient outcomes.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Oncology Precision Medicine Market? AbbVie Acquired Immunogen To Boost Oncology Portfolio

In February 2024, AbbVie Inc., a US-based biopharmaceutical company, acquired Immunogen for $10.1 billion. Through this acquisition, AbbVie aims to accelerate its entry into the solid tumor space and enhance its oncology portfolio by leveraging Immunogen’s commercial infrastructure, established global reach, and promising antibody drug conjugate pipeline beyond ovarian cancer. ImmunoGen Inc. is a US-based biotechnology company that provides antibody-drug conjugates that deliver precision-targeted therapies for treating cancer based on specific tumor biomarkers.

What Is The Regional Outlook For The Global Oncology Precision Medicine Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Oncology Precision Medicine Industry?

The oncology precision medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including the oncology precision medicine industry global market size, regional shares, competitors with the market share, detailed market segments, market trends, and opportunities, and any further data you may need to thrive in the oncology precision medicine industry. This oncology precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Oncology Precision Medicine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$125.14 billion
Revenue Forecast In 2034	$201.40 billion
Growth Rate	CAGR of 12.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Product Type, Technology, Biomarker Types, Applications, End-Users, Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Oncology Precision Medicine Market Characteristics

3. Oncology Precision Medicine Market Trends And Strategies

4. Oncology Precision Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Oncology Precision Medicine Growth Analysis And Strategic Analysis Framework

5.1. Global Oncology Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Oncology Precision Medicine Market Growth Rate Analysis

5.4. Global Oncology Precision Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Oncology Precision Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Oncology Precision Medicine Total Addressable Market (TAM)

6. Oncology Precision Medicine Market Segmentation

6.1. Global Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostics

Therapeutics

Inhibitor Drugs

Monoclonal Antibodies

Cell And Gene Therapy

Antiviral And Anti-Retroviral Drugs

6.2. Global Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genomics

Proteomics

Bioinformatics

Other Technologies

6.3. Global Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Biomarkers

Protein Biomarkers

Epigenetic Biomarkers

Metabolic Biomarkers

Other Biomarker Types

6.4. Global Oncology Precision Medicine Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Cervical Cancer

Kidney Cancer

Liver Cancer

Bladder Cancer

Other Applications

6.5. Global Oncology Precision Medicine Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Laboratories

Research Institutions

Pharmaceutical Companies

Other End-Users

6.6. Global Oncology Precision Medicine Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Companion Diagnostics

Molecular Diagnostics

Liquid Biopsy

Imaging Diagnostics

Next-Generation Sequencing Assays

6.7. Global Oncology Precision Medicine Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tyrosine Kinase Inhibitors (TKIs)

Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors)

Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors)

B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors)

Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

6.8. Global Oncology Precision Medicine Market, Sub-Segmentation Of Inhibitor Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tyrosine Kinase Inhibitors (TKIs)

Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors)

Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors)

B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors)

Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

6.9. Global Oncology Precision Medicine Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Naked Monoclonal Antibodies

Conjugated Monoclonal Antibodies

Bispecific Antibodies

Immune Checkpoint Inhibitors

Radiolabeled Antibodies

6.10. Global Oncology Precision Medicine Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CAR-T Cell Therapies

T-Cell Receptor (TCR) Therapies

Tumor-Infiltrating Lymphocyte (TIL) Therapies

Oncolytic Viral Therapies

Gene Editing And Replacement Therapies

6.11. Global Oncology Precision Medicine Market, Sub-Segmentation Of Antiviral And Anti-Retroviral Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Reverse Transcriptase Inhibitors

Protease Inhibitors

Integrase Strand Transfer Inhibitors

Entry Inhibitors

Antiviral Agents Targeting Virus-Related Cancers

7. Oncology Precision Medicine Market Regional And Country Analysis

7.1. Global Oncology Precision Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Oncology Precision Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oncology Precision Medicine Market

8.1. Asia-Pacific Oncology Precision Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oncology Precision Medicine Market

9.1. China Oncology Precision Medicine Market Overview

9.2. China Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oncology Precision Medicine Market

10.1. India Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oncology Precision Medicine Market

11.1. Japan Oncology Precision Medicine Market Overview

11.2. Japan Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oncology Precision Medicine Market

12.1. Australia Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oncology Precision Medicine Market

13.1. Indonesia Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oncology Precision Medicine Market

14.1. South Korea Oncology Precision Medicine Market Overview

14.2. South Korea Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oncology Precision Medicine Market

15.1. Western Europe Oncology Precision Medicine Market Overview

15.2. Western Europe Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oncology Precision Medicine Market

16.1. UK Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oncology Precision Medicine Market

17.1. Germany Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oncology Precision Medicine Market

18.1. France Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oncology Precision Medicine Market

19.1. Italy Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oncology Precision Medicine Market

20.1. Spain Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oncology Precision Medicine Market

21.1. Eastern Europe Oncology Precision Medicine Market Overview

21.2. Eastern Europe Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oncology Precision Medicine Market

22.1. Russia Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oncology Precision Medicine Market

23.1. North America Oncology Precision Medicine Market Overview

23.2. North America Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oncology Precision Medicine Market

24.1. USA Oncology Precision Medicine Market Overview

24.2. USA Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oncology Precision Medicine Market

25.1. Canada Oncology Precision Medicine Market Overview

25.2. Canada Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oncology Precision Medicine Market

26.1. South America Oncology Precision Medicine Market Overview

26.2. South America Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oncology Precision Medicine Market

27.1. Brazil Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oncology Precision Medicine Market

28.1. Middle East Oncology Precision Medicine Market Overview

28.2. Middle East Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oncology Precision Medicine Market

29.1. Africa Oncology Precision Medicine Market Overview

29.2. Africa Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oncology Precision Medicine Market Competitive Landscape And Company Profiles

30.1. Oncology Precision Medicine Market Competitive Landscape

30.2. Oncology Precision Medicine Market Company Profiles

30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Oncology Precision Medicine Market Other Major And Innovative Companies

31.1. Laboratory Corporation of America Holdings

31.2. Quest Diagnostics Inc.

31.3. Agilent Technologies Inc.

31.4. Illumina Inc.

31.5. bioMérieux S.A.

31.6. Bio-Rad Laboratories Inc.

31.7. Exact Sciences Corporation

31.8. Almac Group Limited

31.9. OPKO Health Inc.

31.10. Natera Inc.

31.11. Myriad Genetics Inc.

31.12. Pacific Biosciences of California Inc.

31.13. Asuragen Inc.

31.14. BGI Group

31.15. ANGLE plc

32. Global Oncology Precision Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oncology Precision Medicine Market

34. Recent Developments In The Oncology Precision Medicine Market

35. Oncology Precision Medicine Market High Potential Countries, Segments and Strategies

35.1 Oncology Precision Medicine Market In 2029 - Countries Offering Most New Opportunities

35.2 Oncology Precision Medicine Market In 2029 - Segments Offering Most New Opportunities

35.3 Oncology Precision Medicine Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Oncology Precision Medicine Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Oncology Precision Medicine Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Oncology Precision Medicine Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Oncology Precision Medicine Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Oncology Precision Medicine Market, Sub-Segmentation Of Inhibitor Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Oncology Precision Medicine Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Oncology Precision Medicine Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Oncology Precision Medicine Market, Sub-Segmentation Of Antiviral And Anti-Retroviral Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Oncology Precision Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Global Oncology Precision Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: China, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: India, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Japan, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Australia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Indonesia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: South Korea, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Western Europe, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: UK, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Germany, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: France, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Italy, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Spain, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Russia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: North America, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: USA, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Canada, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: South America, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Brazil, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Middle East, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Africa, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 82: Roche Holding AG Financial Performance

Table 83: Bristol Myers Squibb Company Financial Performance

Table 84: Abbott Laboratories Financial Performance

Table 85: Novartis AG Financial Performance

Table 86: Gilead Sciences Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Oncology Precision Medicine Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Oncology Precision Medicine Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Oncology Precision Medicine Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Oncology Precision Medicine Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Oncology Precision Medicine Market, Sub-Segmentation Of Inhibitor Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Oncology Precision Medicine Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Oncology Precision Medicine Market, Sub-Segmentation Of Cell And Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Oncology Precision Medicine Market, Sub-Segmentation Of Antiviral And Anti-Retroviral Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Oncology Precision Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Global Oncology Precision Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Asia-Pacific, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: China, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: India, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Japan, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Australia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Indonesia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: South Korea, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Western Europe, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: UK, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Germany, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: France, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Italy, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Spain, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Eastern Europe, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Russia, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: North America, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: USA, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Canada, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: South America, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Brazil, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Middle East, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Oncology Precision Medicine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Oncology Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Africa, Oncology Precision Medicine Market, Segmentation By Biomarker Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 82: Roche Holding AG Financial Performance

Figure 83: Bristol Myers Squibb Company Financial Performance

Figure 84: Abbott Laboratories Financial Performance

Figure 85: Novartis AG Financial Performance

Figure 86: Gilead Sciences Inc. Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Clinical Oncology Next Generation Sequencing Global Market Report 2025 – By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termi...

Oncology Devices Global Market Report 2025 – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy), By End User (Hospitals, Can...

Oncology Biomarkers Global Market Report 2025 – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioin...

Oncology Information Systems Global Market Report 2025 – By Product (Solutions, Professional Services), By Application (Medical Oncology, Radiation Oncology, Surgical Oncology), By End User (Hospitals And Diagnostic Imag...

Generic Oncology Drugs Global Market Report 2025 – By Molecule Type (Large Molecule, Small Molecule), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pha...

Precision Medicine Global Market Report 2025 – By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology), By Application (Oncology, Respiratory Diseases,...

Frequently Asked Questions

What is the definition of the Oncology Precision Medicine market?

How will the Oncology Precision Medicine market drivers and restraints affect the market dynamics? What forces will shape the Oncology Precision Medicine industry going forward?

The Oncology Precision Medicine market major growth driver - The Growing Prevalence Of Cancer Is Enhancing The Market Growth Due To Aging Populations. For further insights on the Oncology Precision Medicine market, request a sample here

What is the forecast market size or the forecast market value of the Oncology Precision Medicine market?

The Oncology Precision Medicine market size has grown strongly in recent years. The oncology precision medicine market size has grown rapidly in recent years. It will grow from $110.90 billion in 2024 to $125.14 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to rising prevalence of cancer cases, increasing adoption of targeted therapies, growing investments in genomic research, expanding healthcare infrastructure, and rising awareness about personalized medicine. The oncology precision medicine market size is expected to see rapid growth in the next few years. It will grow to $201.40 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing demand for non-invasive cancer diagnostics, growing preference for individualized treatment approaches, rising use of companion diagnostics, expanding pipeline of precision oncology drugs, and increasing clinical adoption of artificial intelligence tools. Major trends in the forecast period include technology advancements in liquid biopsy platforms, innovations in next-generation sequencing, developments in artificial intelligence for data analysis, research and developments in biomarker discovery, and integration of multi-omics in clinical oncology. For further insights on the Oncology Precision Medicine market, request a sample here

How is the Oncology Precision Medicine market segmented?

The oncology precision medicine market covered in this report is segmented –
1) By Product Type: Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs
2) By Technology: Genomics, Proteomics, Bioinformatics, Other Technologies
3) By Biomarker Types: Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types
4) By Applications: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications
5) By End-Users: Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users Subsegments:
1) By Diagnostics: Companion Diagnostics, Molecular Diagnostics, Liquid Biopsy, Imaging Diagnostics, Next-Generation Sequencing Assays
2) By Therapeutics: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)
3) By Inhibitor Drugs: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)
4) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, Radiolabeled Antibodies
5) By Cell And Gene Therapy: CAR-T Cell Therapies, T-Cell Receptor (TCR) Therapies, Tumor-Infiltrating Lymphocyte (TIL) Therapies, Oncolytic Viral Therapies, Gene Editing And Replacement Therapies
6) By Antiviral And Anti-Retroviral Drugs: Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Entry Inhibitors, Antiviral Agents Targeting Virus-Related Cancers For further insights on the Oncology Precision Medicine market, request a sample here

Which region has the largest share of the Oncology Precision Medicine market? What are the other regions covered in the report?

North America was the largest region in the oncology precision medicine market in 2024. The regions covered in the oncology precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Oncology Precision Medicine market, request a sample here.

Who are the major players in the Oncology Precision Medicine market?

What are the key trends in the Oncology Precision Medicine market?

Major trends in the Oncology Precision Medicine market include Advancing Personalized Cancer Care Through Collaborative Technology And Multidisciplinary Expertise. For further insights on the Oncology Precision Medicine market, request a sample here.